- Apr 2022
-
twitter.com twitter.com
-
John Kerr. (2021, March 22). As in another study, https://t.co/hl7qce6x4t, some messages ⬆️ feeling informed, but weirdly, these were the least informative, raising some Qs about how best to measure and change people’s awareness of the risks & benefits ethically. 7/n https://t.co/HAGeje5afy [Tweet]. @SciComGuy. https://twitter.com/SciComGuy/status/1374040006034096131
-
- May 2021
-
path.azureedge.net path.azureedge.net
-
Childrenís Vaccine Program at PATH. Guidelines for Implementing Supportive Supervision:A step-by-step guide with tools to support immunization. Seattle: PATH (2003)
-
-
www.who.int www.who.int
-
Reducing pain at the time of vaccination: WHO Position Paper – September 2015. Weekly epidemiological record. 2015;90(39):505–16 (www.who.int /immunization/policy/position_papers /reducing_pain_vaccination/en/)
-
- Mar 2021
-
-
Wise, J. (2021). Covid-19: Extra 1.7 million people in England are asked to shield. BMJ, 372, n467. https://doi.org/10.1136/bmj.n467
-
- Feb 2021
-
www.thelancet.com www.thelancet.com
-
Siva, N. (2021). Severe mental illness: Reassessing COVID-19 vaccine priorities. The Lancet, 397(10275), 657. https://doi.org/10.1016/S0140-6736(21)00429-3
-
-
www.who.int www.who.int
-
Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca. (n.d.). Retrieved 16 February 2021, from https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-vaccines-SAGE_recommendation-AZD1222-2021.1
-